| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Bruno Julianne | Director | C/O GALECTO, INC.,, 75 STATE STREET, SUITE 100, BOSTON | /s/ Lori Firmani, attorney-in-fact | 12 Feb 2026 | 0002019645 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GLTO | Common Stock | Options Exercise | $0 | +129,000 | +1606% | $0.000000 | 137,032 | 09 Feb 2026 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GLTO | Series C Preferred Stock | Options Exercise | $0 | -129 | -100% | $0.000000 | 0 | 09 Feb 2026 | Common Stock | 129,000 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | On February 9, 2026, the Issuer's stockholders approved the issuance of Common Stock upon conversion of the Issuer's Series C Non-Voting Convertible Preferred Stock, par value $0.00001 per share ("Series C Preferred Stock") (the "Requisite Stockholder Approval"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock, 129 shares of Series C Preferred Stock held by the Reporting Person were converted into 129,000 shares of Common Stock. The securities of the Issuer held by the Reporting Person, including the shares of Common Stock received upon conversion of the Series C Preferred Stock, are subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 60 days |
| F2 | (Continued from footnote 1) following the date of the final prospectus supplement relating to the public offering, which was February 10, 2026. |
| F3 | Following receipt of the Requisite Stockholder Approval, each share of Series C Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain beneficial ownership limitations. The Series C Preferred Stock has no expiration date. |